Quantcast

Latest Benzimidazoles Stories

2011-08-10 08:00:00

SEATTLE, Aug. 10, 2011 /PRNewswire/ -- The following statement is being issued by GCG Inc., Notice Administrator regarding the Commonwealth Care Alliance v. AstraZeneca Pharmaceuticals L.P., Docket No. 05-0269. If You Purchased the Drug Nexium® (esomeprazole magnesium) in Massachusetts, A Class Action Lawsuit May Affect Your Rights. There is a class action lawsuit pending in Suffolk County Superior Court in the Commonwealth of Massachusetts ("Lawsuit"). The name of the...

2011-07-27 00:01:19

Horse Gold Unique Proprietary Formula Obliterates Gastric Pain in Horses Bradenton, FL (PRWEB) July 26, 2011 Horse Gold, makers of hyper-effective equine supplements created by horsemen for horsemen, officially released Gastromax3â“ž¢ paste, an affordable, once-a-day preventive anti-ulcer supplement for horses. Gastromax3â“ž¢ paste is formulated to prevent debilitating ulcers using omeprazole, a protein pump inhibitor that blocks the...

2011-07-21 07:00:00

RIDGEFIELD, Conn., July 21, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that Pradaxa® (dabigatran etexilate mesylate) capsules has been added to hospital formularies at 49 of the top 50 cardiology and heart surgery hospitals, as ranked by U.S. News & World Report's Best Hospitals 2011-2012, published online on July 19. PRADAXA is approved by the U.S. Food and Drug Administration (FDA) to reduce the risk of stroke and...

2011-05-19 07:00:00

RIDGEFIELD, Conn., May 19, 2011 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that Pradaxa® (dabigatran etexilate mesylate) capsules has received preferred Tier 2 formulary status with all AARP Medicare Part D plans through its pharmacy benefits manager, Prescription Solutions®. The AARP plans, which include AARP Medicare Rx and AARP MedicareComplete from Secure Horizons, provide prescription drug access to nearly 6.8...

2011-05-18 00:17:45

In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA. "GERD is a highly prevalent disorder caused by the reflux of gastric contents into the esophagus. It is a chronic, relapsing disease that negatively affects...

2011-04-19 09:45:00

HOUSTON, April 19, 2011 /PRNewswire/ -- An Ohio woman suffered bone deterioration and broken bones because of hidden risks with pharmaceutical giant AstraZeneca's acid reflux drug Nexium, The Gibson Law Firm alleges in a lawsuit filed today in Texas federal court. Filed in the U.S. District Court in Houston, the lawsuit alleges 58-year-old Ginny Begin, of Toledo, Ohio, suffered serious bone deterioration after taking Nexium on a daily basis between 2003 and early 2011. In March, the FDA...

2011-04-05 09:30:00

NEW ORLEANS, April 5, 2011 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (Takeda) announced the presentation of new study results, which evaluated the potential inhibitory effects of certain proton pump inhibitors (PPIs) on Plavix (clopidogrel bisulfate). The results showed that in healthy subjects, clopidogrel's active metabolite and inhibition of platelet function were reduced less by the co-administration of clopidogrel with dexlansoprazole or lansoprazole, rather than...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.